{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-001744","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.482085+00:00","generated_at":"2026-06-17T23:25:39.209952+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"United-Guardian FY 2022 net income drops 45% to $2.57M; EPS $0.56 vs $1.01","bullets":["Net sales fell 9% to $12.7M from $13.9M; cosmetic ingredient revenue declined, securities portfolio losses increased.","Net income $2,569,512 ($0.56 diluted EPS) vs $4,658,542 ($1.01) in prior year, a 45% decrease.","Downside blamed on contract manufacturer overstocking in 2021 and China's zero-COVID policy reducing Asian demand.","Pharmaceutical and medical lubricants business remained strong in 2022; company focused on hydrogel innovation.","No forward guidance or dividend changes announced in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-001744","json":"https://secwatch.observer/filing/0001171843-23-001744.json","markdown":"https://secwatch.observer/filing/0001171843-23-001744.md","text":"https://secwatch.observer/filing/0001171843-23-001744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184323001744/0001171843-23-001744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184323001744/f8k_031723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:25:39.209952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b5152b5470536c98b551774f81b6866ca1918f0","claim":"UNITED GUARDIAN INC reported FY 2022 results: revenue $12,698,503, net income $2,569,512 ($0.56 per share), EPS $0.56 per share.","evidence_excerpt":"Net sales for the year decreased by 9% from $13,929,629 in 2021 to $12,698,503 in 2022, generating net income of $2,569,512 ($0.56 per share) in 2022 compared to $4,658,542 ($1.01 per share) in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/101295/000117184323001744/0001171843-23-001744-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY 2022"},{"label":"Revenue","value":"$12,698,503"},{"label":"Net income","value":"$2,569,512 ($0.56 per share)"},{"label":"EPS","value":"$0.56 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}